131 related articles for article (PubMed ID: 16270631)
1. Tissue factor pathway inhibitor and the risk of recurrent venous thromboembolism.
Hoke M; Kyrle PA; Minar E; Bialonzcyk C; Hirschl M; Schneider B; Kollars M; Weltermann A; Eichinger S
Thromb Haemost; 2005 Oct; 94(4):787-90. PubMed ID: 16270631
[TBL] [Abstract][Full Text] [Related]
2. Symptomatic pulmonary embolism and the risk of recurrent venous thromboembolism.
Eichinger S; Weltermann A; Minar E; Stain M; Schönauer V; Schneider B; Kyrle PA
Arch Intern Med; 2004 Jan; 164(1):92-6. PubMed ID: 14718328
[TBL] [Abstract][Full Text] [Related]
3. The risk of recurrent venous thromboembolism in patients with and without factor V Leiden.
Eichinger S; Pabinger I; Stümpflen A; Hirschl M; Bialonczyk C; Schneider B; Mannhalter C; Minar E; Lechner K; Kyrle PA
Thromb Haemost; 1997 Apr; 77(4):624-8. PubMed ID: 9134632
[TBL] [Abstract][Full Text] [Related]
4. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism.
Kyrle PA; Minar E; Hirschl M; Bialonczyk C; Stain M; Schneider B; Weltermann A; Speiser W; Lechner K; Eichinger S
N Engl J Med; 2000 Aug; 343(7):457-62. PubMed ID: 10950667
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms of the tissue factor pathway inhibitor gene are associated with venous thromboembolism in the antiphospholipid syndrome and carriers of factor V Leiden.
Lincz LF; Adams MJ; Scorgie FE; Thom J; Baker RI; Seldon M
Blood Coagul Fibrinolysis; 2007 Sep; 18(6):559-64. PubMed ID: 17762532
[TBL] [Abstract][Full Text] [Related]
6. Circulating P-selectin and the risk of recurrent venous thromboembolism.
Kyrle PA; Hron G; Eichinger S; Wagner O
Thromb Haemost; 2007 Jun; 97(6):880-3. PubMed ID: 17549288
[TBL] [Abstract][Full Text] [Related]
7. High-density lipoprotein and the risk of recurrent venous thromboembolism.
Eichinger S; Pecheniuk NM; Hron G; Deguchi H; Schemper M; Kyrle PA; Griffin JH
Circulation; 2007 Mar; 115(12):1609-14. PubMed ID: 17372172
[TBL] [Abstract][Full Text] [Related]
8. Incidence of venous thromboembolism in first-degree relatives of patients with venous thromboembolism who have factor V Leiden.
Couturaud F; Kearon C; Leroyer C; Mercier B; Abgrall JF; Le Gal G; Lacut K; Oger E; Bressollette L; Ferec C; Lamure M; Mottier D;
Thromb Haemost; 2006 Dec; 96(6):744-9. PubMed ID: 17139368
[TBL] [Abstract][Full Text] [Related]
9. Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped.
Palareti G; Legnani C; Cosmi B; Guazzaloca G; Pancani C; Coccheri S
Thromb Haemost; 2002 Jan; 87(1):7-12. PubMed ID: 11848459
[TBL] [Abstract][Full Text] [Related]
10. Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity.
Strandberg K; Svensson PJ; Ohlin AK
Thromb Res; 2007; 121(2):145-51. PubMed ID: 17499343
[TBL] [Abstract][Full Text] [Related]
11. Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model.
Eichinger S; Heinze G; Jandeck LM; Kyrle PA
Circulation; 2010 Apr; 121(14):1630-6. PubMed ID: 20351233
[TBL] [Abstract][Full Text] [Related]
12. Abnormally short activated partial thromboplastin time values are associated with increased risk of recurrence of venous thromboembolism after oral anticoagulation withdrawal.
Legnani C; Mattarozzi S; Cini M; Cosmi B; Favaretto E; Palareti G
Br J Haematol; 2006 Jul; 134(2):227-32. PubMed ID: 16846482
[TBL] [Abstract][Full Text] [Related]
13. Family history for venous thromboembolism and the risk for recurrence.
Hron G; Eichinger S; Weltermann A; Minar E; Bialonczyk C; Hirschl M; Stain M; Gartner V; Kyrle PA
Am J Med; 2006 Jan; 119(1):50-3. PubMed ID: 16431184
[TBL] [Abstract][Full Text] [Related]
14. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
[TBL] [Abstract][Full Text] [Related]
15. The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism--results from a randomized, double-blind, clinical trial.
Høibraaten E; Qvigstad E; Andersen TO; Mowinckel MC; Sandset PM
Thromb Haemost; 2001 May; 85(5):775-81. PubMed ID: 11372667
[TBL] [Abstract][Full Text] [Related]
16. Prothrombin fragment F1+2 is not predictive for recurrent venous thromboembolism.
Kyrle PA; Eichinger S; Pabinger I; Stümpflen A; Hirschl M; Bialonczyk C; Schneider B; Mannhalter C; Melichart M; Traxler G; Weltermann A; Speiser W; Lechner K
Thromb Haemost; 1997 May; 77(5):829-33. PubMed ID: 9184387
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia.
Palareti G; Legnani C; Cosmi B; Valdré L; Lunghi B; Bernardi F; Coccheri S
Circulation; 2003 Jul; 108(3):313-8. PubMed ID: 12847064
[TBL] [Abstract][Full Text] [Related]
18. Co-segregation of thrombophilic disorders in factor V Leiden carriers; the contributions of factor VIII, factor XI, thrombin activatable fibrinolysis inhibitor and lipoprotein(a) to the absolute risk of venous thromboembolism.
Libourel EJ; Bank I; Meinardi JR; Baljé -Volkers CP; Hamulyak K; Middeldorp S; Koopman MM; van Pampus EC; Prins MH; Büller HR; van der Meer J
Haematologica; 2002 Oct; 87(10):1068-73. PubMed ID: 12368162
[TBL] [Abstract][Full Text] [Related]
19. Superficial thrombophlebitis and risk for recurrent venous thromboembolism.
Schönauer V; Kyrle PA; Weltermann A; Minar E; Bialonczyk C; Hirschl M; Quehenberger P; Schneider B; Partsch H; Eichinger S
J Vasc Surg; 2003 Apr; 37(4):834-8. PubMed ID: 12663985
[TBL] [Abstract][Full Text] [Related]
20. Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism.
Eichinger S; Stümpflen A; Hirschl M; Bialonczyk C; Herkner K; Stain M; Schneider B; Pabinger I; Lechner K; Kyrle PA
Thromb Haemost; 1998 Oct; 80(4):566-9. PubMed ID: 9798970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
